Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Direct extubation versus extubation after a spontaneous breathing trial in low-risk patients

Official title: Direct Extubation Versus Extubation After a Spontaneous Breathing Trial in Patients at Low Risk of Extubation Failure

Run by Assistance Publique - Hôpitaux de Paris · NCT07019636 · Data updated 2026-11-12

This trial tests whether skipping a spontaneous breathing trial and directly extubating is safe and helps more patients come off the ventilator within 24 hours in people who are ready to wean and at low risk of extubation failure.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment314 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedSeptember 18, 2028
Study endsOctober 15, 2028
Registry record updatedJuly 17, 2026
Trial IDNCT07019636 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 to under 65 years who have been intubated for more than 24 hours and less than 4 days, and who meet predefined readiness-to-wean criteria with low risk of extubation failure.

Probably not a fit

Patients with higher risk factors for extubation failure or comorbidities not meeting readiness criteria may not benefit from direct extubation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, open-label study compares two weaning strategies for adults on mechanical ventilation who meet readiness-to-wean criteria and are considered at low risk for extubation failure. One arm uses a direct extubation approach, while the other requires a successful spontaneous breathing trial before extubation. The primary endpoint is the proportion of patients extubated successfully within 24 hours after randomization. The study aims to determine if omitting the SBT can increase timely extubation without increasing failure. Safety considerations include avoiding unnecessary delays or extubation failure in this specific low-risk population.

Why it matters

Potential benefit: If successful, the direct extubation approach could shorten ventilation time and ICU stay for suitable patients.

How similar studies have gone: Previous approaches using readiness criteria and SBTs have shown variable results; this trial tests a novel direct-extubation strategy in a low-risk group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age older than 18 years and \< 65 years old
* Nasal or oral intubation longer than 24 hours and less than 4 days
* Satisfaction to each following weaning readiness criteria:

  1. Respiratory rate \< 35 cycles per minute
  2. SpO2 \>90% with FiO2\<40% and PEEP\<8 cmH2O
  3. RASS score between -2 and +2 with low level or no sedatives
  4. No need or low doses of vasopressors
  5. Adequate cough
* Inform consent by patient or legal representative or the close relative or emergency inclusion procedure.

Exclusion Criteria:

* Risk factor for extubation failure as defined by any of the following criteria:

  * Chronic cardiac disease (left ejection fraction below 45%, documented history of cardiogenic pulmonary edema, permanent atrial fibrillation).
  * Chronic respiratory disease (severe COPD, documented restricted lung disease or obesity-hypoventilation syndrome)
  * Body mass index \> 30 kg/m2
  * Airway patency problems, including high risk of developing laryngeal edema, inability to deal with respiratory secretions, brain injury, documented swallowing disorders
* Tracheostomy
* Underlying chronic neuromuscular disease
* Do not resuscitate orders
* Pregnant or lacting woman
* Patient under guardianship
* Patient without healthcare insurance
* Refusal to participate and sign the written consent
* Patients with traumatic brain injury
* Post surgery patients
* Patients included in another interventional trial that may have an impact on the evaluation criteria of the present study
* Patient under AME

Where it's running

  • Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Martin DRES, Pr — Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
  • Study coordinator: Martin DRES, Pr
  • Email: martin.dres@aphp.fr
  • Phone: 01 42 16 77 97

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.